New developments in pediatric cardiac anesthesia.
As the practice of pediatric cardiac anesthesia continues to grow, anesthesiologists now routinely care for patients ranging in size from less than 2 kg to more than 100 kg. New clinical and laboratory research has enhanced our understanding of the effects of anesthetic drugs on the pediatric myocardium, and improvements in survival statistics for even the smallest and sickest infants have shifted the emphasis to evaluation of quality of life and neurological outcome in pediatric cardiac patients. The use of circulatory support in infants and children, both for rapid resuscitation and for more chronic indications such as bridge to transplantation, also continues to evolve, with the recent introduction of pulsatile and axial pumps for pediatric use. This article reviews anesthetic agents, bleeding and coagulation, neurological monitoring, and mechanical circulatory support in the treatment of infants and children.
Diaz
Laura K
LK
The Arthur S. Keats Division of Pediatric Cardiovascular Anesthesiology, Texas Children's Hospital, Houston, TX 77030, USA. lkdiaz@bcm.tmc.edu
Andropoulos
Dean B
DB
D000758:Anesthesia; D000776:Anesthesiology / Q000295:instrumentation; D000777:Anesthetics; D001778:Blood Coagulation Disorders / Q000517:prevention & control; D016063:Blood Loss, Surgical / Q000517:prevention & control; D006348:Cardiac Surgical Procedures; D002648:Child; D004569:Electroencephalography; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D016343:Monitoring, Intraoperative; D016896:Treatment Outcome
D000777:Anesthetics